International Stem Cell Corporation Arranges $3 Million Equity Financing
OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three tranches. The first, for $700,000, closed August 20, 2008. The second closing for $1,300,000 is scheduled for September 23, 2008 and the final closing of $1,000,000 is scheduled for December 15, 2008, subject to determination by the investor that no material adverse event has occurred. The investor will ...
Source: International Stem Cell Corporation - September 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
International Stem Cell Corporation Arranges $3 Million Equity Financing
OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three tranches. The first, for $700,000, closed August 20, 2008. The second closing for $1,300,000 is scheduled for September 23, 2008 and the final closing of $1,000,000 is scheduled for December 15, 2008, subject to determination by the investor that no material adverse event has occ...
Source: International Stem Cell Corporation - September 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
International Stem Cell Corporation Arranges $3 Million Equity Financing
OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three tranches. The first, for $700,000, closed August 20, 2008. The second closing for $1,300,000 is scheduled for September 23, 2008 and the final closing of $1,000,000 is scheduled for December 15, 2008, subject to determination by the investor that no material adverse event has occurred. The investor will ...
Source: International Stem Cell Corporation - September 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
International Stem Cell Corporation Arranges $3 Million Equity Financing
OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three tranches. The first, for $700,000, closed August 20, 2008. The second closing for $1,300,000 is scheduled for September 23, 2008 and the final closing of $1,000,000 is scheduled for December 15, 2008, subject to determination by the investor that no material adverse event has occ...
Source: International Stem Cell Corporation - September 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
International Stem Cell Corporation Arranges $3 Million Equity Financing
OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three tranches. The first, for $700,000, closed August 20, 2008. The second closing for $1,300,000 is scheduled for September 23, 2008 and the final closing of $1,000,000 is scheduled for December 15, 2008, subject to determination by the investor that no material adverse event has occurred. The investor will ...
Source: International Stem Cell Corporation - September 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
JAMA: 2008-06-25, Vol. 299, No. 24, Author in the Room ™ Audio Interview
Interview with Beverly Beth Green, MD, MPH, author of Effectiveness of Home Blood Pressure Monitoring, Web Communication, and Pharmacist Care on Hypertension Control: The e-BP Randomized Controlled Trial. Summary Points: 1. If blood pressure (BP) control could be improved, many deaths from cardiovascular and renal disease could be prevented. 2. The Chronic Care Model was used to design an intervention that empowered patients to be more involved in their own care using home BP monitoring, a patient shared electronic medical record, and Web-based pharmacist assistance. 3. The group of patients that received BP monitors and t...
Source: JAMA Author in the Room - August 26, 2008 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA: 2008-06-25, Vol. 299, No. 24, Author in the Room™ Audio Interview
Interview with Beverly Beth Green, MD, MPH, author of Effectiveness of Home Blood Pressure Monitoring, Web Communication, and Pharmacist Care on Hypertension Control: The e-BP Randomized Controlled Trial. Summary Points: 1. If blood pressure (BP) control could be improved, many deaths from cardiovascular and renal disease could be prevented. 2. The Chronic Care Model was used to design an intervention that empowered patients to be more involved in their own care using home BP monitoring, a patient shared electronic medical record, and Web-based pharmacist assistance. 3. The group of patients that received BP monitors and t...
Source: JAMA Author in the Room - August 26, 2008 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Anxiety- the 21st Century Disease of Civilization With Dr. Peter T. Lambrou
Today’s podcast is a conversation between Dr. Gurr and Dr. Peter T. Lambrou on anxiety in our society, when it becomes a problem, and what helps to reduce anxiety.
The guest or today, Dr. Peter Lambrou is a licensed clinical psychologist and Chairman of Psychology at Scripps Memorial Hospital, La Jolla, California (2008 - 2009), where he has maintained a private practice since 1987, and he is on the teaching faculty of the University of California at San Diego. Dr. Lambrou is a Fellow of the American Institute of Stress, a Diplomate in Behavioral Medicine among many affiliations. He is also the co-auth...
Source: The Shrink Is In - August 16, 2008 Category: Psychiatry & Psychology Authors: DrGurr Source Type: podcasts
A Frank Discussion About Stem Cell Research with International Stem Cell CEO
Ken Aldrich, CEO of International Stem Cell Corporation, addresses some timely issues regarding stem cell research. To learn more about ISCO or to contact them regarding further questions, please visit their website here (Source: International Stem Cell Corporation)
Source: International Stem Cell Corporation - July 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
A Frank Discussion About Stem Cell Research with International Stem Cell CEO
Ken Aldrich, CEO of International Stem Cell Corporation, addresses some timely issues regarding stem cell research. To learn more about ISCO or to contact them regarding further questions, please visit their website here (Source: International Stem Cell Corporation)
Source: International Stem Cell Corporation - July 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
Dr. John Ryder Talks About Corporate Mentality
Today’s podcast is a conversation between Dr. Howard Gurr and Dr. John Ryder on psychology in the corporate world and the corporate mentality. Dr.John Ryder is a licensed psychologist with a private practice in Manhattan. After earning his doctorate in psychology at the City University of New York, he served as an Assistant Professor at Mt. Sinai Medical Center. Traveling around the world, he has studied the secrets to a healthy and successful life with many of the most respected leaders of both Western and Eastern traditions. Dr. Ryder has been a consultant to many successful individuals, corporate executives, athle...
Source: The Shrink Is In - May 20, 2008 Category: Psychiatry & Psychology Authors: DrGurr Source Type: podcasts
